Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 143, Issue , 2016, Pages 271-277

  Thapa, Raj Kumar ^a   Youn, Yu Seok ^b   Jeong, Jee Heon ^a   Choi, Han Gon ^c   Yong, Chul Soon ^a   Kim, Jong Oh ^a  

^a Yeungnam University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Docetaxel; Graphene oxide; Liquid crystalline nanoparticle; Near infrared; Prostate cancer

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CRYSTALLINE MATERIALS; GRAPHENE; HYBRID SYSTEMS; INFRARED DEVICES; LIQUIDS; NANOPARTICLES; PARTICLE SIZE; UROLOGY;

DOCETAXEL; GRAPHENE OXIDES; LIQUID CRYSTALLINE NANOPARTICLES; NEAR INFRARED; PROSTATE CANCERS;

DISEASES;

DOCETAXEL; GRAPHENE OXIDE; LIQUID CRYSTALLINE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; GRAPHITE; MACROGOL DERIVATIVE; OXIDE; TAXOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CHEMO PHOTOTHERMAL THERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; MALE; METASTATIC PROSTATE CANCER CELL; MIGRATION INHIBITION; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; CELL MOTION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; INFRARED SPECTROSCOPY; LIQUID CRYSTAL; METABOLISM; METASTASIS; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; PROSTATE TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DRUG LIBERATION; GRAPHITE; HUMANS; LIQUID CRYSTALS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NEOPLASM METASTASIS; OXIDES; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TAXOIDS;

EID: 84961935880     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.03.045     Document Type: Article

References (27)

1. Droz J.P., Chaladaj A. BJU Int. 2008, 101:23-29.
2. Jemal A., Siegel R., Xu J., Ward E. CA Cancer J. Clin. 2010, 60:277-300.
3. Shen M.M., Abate-Shen C. Genes Dev. 2010, 24:1967-2000.
4. Josson S., Nomura T., Lin J.T., Huang W.C., Wu D., Zhau H.E., Zayzafoon M., Weizmann M.N., Gururajan M., Chung L.W. Cancer Res. 2011, 17:2600-2610.
5. Diaz M., Patterson S.G. Cancer Control 2004, 11:364-373.
6. Lassi K., Dawson N.A. Curr. Opin. Oncol. 2010, 22:263-267.
7. Tannock I.F., de Wit R., Berry W.R., Horti J., Pluzanska A., Chi K.N., Oudard S., Theodore C., James N.D., Turesson I., Rosenthal M.A., Eisenberger M.A. N. Engl. J. Med. 2004, 351:1502-1512.
8. Petrylak D.P., Tangen C.M., Hussain M.H., Lara P.N., Jones J.A., Taplin M.E., Burch P.A., Berry D., Moinpour C., Kohli M., Benson M.C., Small E.J., Raghavan D., Crawford E.D. N. Engl. J. Med. 2004, 351:1513-1520.
9. Niraula S., Tannock I.F. Acta Oncol. 2011, 50:141-147.
10. Lee S.Y., Cho J.S., Yuk D.Y., Moon D.C., Jung J.K., Yoo H.S., Lee Y.M., Han S.B., Oh K.W., Hong J.T. J. Pharmacol. Sci. 2009, 111:124-136.
11. Dirican A., Atmaca H., Bozkurt E., Erten C., Karaca B., Uslu R. Clin. Transl. Oncol. 2015, 17:145-151.
12. Thapa R.K., Baskaran R., Madheswaran T., Kim J.O., Yong C.S., Yoo B.K. J. Disper. Sci. Technol. 2013, 34:72-77.
13. Thapa R.K., Yoo B.K. J. Dermatol. Treat. 2014, 25:22-25.
14. Thapa R.K., Choi J.Y., Poudel B.K., Hiep T.T., Pathak S., Gupta B., Choi H.G., Yong C.S., Kim J.O. ACS Appl. Mater. Interfaces 2015, 7:20360-20368.
15. Kim H., Lee D., Kim J., Kim T.I., Kim W.J. ACS Nano 2013, 7:6735-6746.
16. Robinson J.T., Tabakman S.M., Liang Y., Wang H., Casalongue H.S., Vinh D., Dai H. J. Am. Chem. Soc. 2011, 133:6825-6831.
17. Zhang W., Guo Z., Huang D., Liu Z., Guo X., Zhong H. Biomaterials 2011, 32:8555-8561.
18. Ameller T., Marsaud V., Legrand P., Gref R., Barratt G., Renoir J.M. Pharm. Res. 2003, 20:1063-1070.
19. Rahmanian N., Hamishehkar H., Dolatabadi J.E., Arsalani N. Colloids Surf. B Biointerfaces 2014, 123:331-338.
20. Fernandes J.C., Qiu X., Winnik F.M., Benderdour M., Zhang X., Dai K., Shi Q. Int. J. Nanomed. 2012, 7:5833-5845.
21. Vennin C., Spruyt N., Dahmani F., Julien S., Bertucci F., Finetti P., Chassat T., Bourette R.P., Le X., Bourhis E. Adriaenssens Oncotarget 2015, 6:29209-29223.
22. Logie J., McLaughlin C.K., Tam R.Y., Shoichet M.S. Chem. Commun. 2015, 51:12000-12003.
23. Xu P., Meng Q., Sun H., Yin Q., Yu H., Zhang Z., Cao M., Zhang Y., Li Y. Biomaterials 2015, 64:10-20.
24. Chang S.H., Lin H.T., Wu G.J., Tsai G.J. Carbohydr. Polym. 2015, 134:74-81.
25. Toner A.P., McLaughlin F., Giles F.J., Sullivan F.J., O'Connell E., Carleton L.A., Breen L., Dunne G., Gorman A.M., Lewis J.D., Glynn S.A. Br. J. Cancer 2013, 109:2131-2141.
26. Galaup A., Opolon P., Bouguet C., Li H., Opolon D., Bissery M.C., Tursz T., Perricaudet M., Griscelli F. Mol. Ther. 2003, 7:731-740.
27. Choi Y.H., Yoo Y.H. Oncol. Rep. 2012, 28:2163-2169.